Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies
The incidence rate of invasive mucormycosis (IM) in patients with hematological malignancies (HMs) is increasing year by year, ranging from 0.07% to 4.29%, and the mortality rate is mostly higher than 50%. With the ongoing pandemic of COVID-19, COVID-19-associated mucormycosis (CAM) also became a gl...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2023-05-01
|
| Seri Bilgileri: | Journal of Fungi |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/2309-608X/9/5/592 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|